e-Therapeutics Appoints Daniel Elger as Chief Financial Officer

14-Jun-2011 - United Kingdom

e-Therapeutics plc announced that Dr Daniel Elger will be joining the Company and its Board as Chief Financial Officer, with immediate effect.

Dr Elger, 41, was previously the VP, Marketing & Communications at cancer drug developer Antisoma plc. He joined that company in 2002 and served on its Senior Management Team from 2005, playing significant roles in corporate strategy, fundraisings and the acquisition of two US biotech companies. He also directed the investor relations strategy for the Company. Before Antisoma, Daniel was a Programme Director for major pharmaceutical companies at a leading marketing and communications agency. He holds a BA in Physiological Sciences (Medicine) and a PhD in cancer cell biology, both from Oxford University.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances